Images List Premium Download Classic

Kinetics

Kinetics-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Release-matrices for controlled release of materials into a surrounding medium
Kuhner Shaker Gmbh
March 29, 2018 - N°20180087025

The present invention refers to release matrices which include a material that can be released in a controlled way or with predefined kinetics into a surrounding medium, reaction vessels comprising said release matrices, and release system further comprising a medium which is able to dissolve the embedded material. The present invention further refers to the use of release matrices in ...
Novel tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
Sirna Therapeutics, Inc.
March 22, 2018 - N°20180079769

Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetragalnac ligands of formula (i), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; 4) one or more peptides independently selected from table 3, which may be the same or different; and optionally, 5) one or more targeting ligands, solubilizing agents, ...
Inhibition of formation of amyloid b-protein fibrils using cactus mucilage extracts
University Of South Florida
March 22, 2018 - N°20180078595

Alzheimer' s disease (ad) is the common neurodegenerative disorder characterized by the formation of extraneuronal accumulation of amyloid fibrils and intracellular neurofibrillary tangles of amyloid β-protein (aβ) into plaques. Cactus mucilage extracted from opuntia ficus-indica was analyzed in disturbing the aggregation pathway of amyloid β-protein (aβ) fibrils and α-synuclein. Mucilage ...
Kinetics Patent Pack
Download 99+ patent application PDFs
Kinetics Patent Applications
Download 99+ Kinetics-related PDFs
For professional research & prior art discovery
inventor
  • 99+ full patent PDF documents of Kinetics-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Sorbents for carbon dioxide reduction from indoor air
Enverid Systems, Inc.
March 15, 2018 - N°20180071672

A sorbent for co2 reduction from indoor air from an enclosed space. In some embodiments, the sorbent comprises a solid support and an amine-based compound being supported by the support. The sorbent captures at least a portion of the co2 within the indoor air. The sorbent may be regenerated by streaming outdoor air through the sorbent to release at least ...
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Clarus Therapeutics, Inc.
March 15, 2018 - N°20180071311

A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e. G., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided.
Method and system for selecting drug on basis of individual protein damage information for preventing ...
Cipherome, Inc.
March 08, 2018 - N°20180068056

The present invention relates to a method and a system for selecting a drug customized on the basis of individual protein information by using individual genome sequences. The method and the system of the present invention can predict the individual side effects or danger of a certain drug by analyzing the sequence of the exon region of a gene encoding ...
Kinetics Patent Pack
Download 99+ patent application PDFs
Kinetics Patent Applications
Download 99+ Kinetics-related PDFs
For professional research & prior art discovery
inventor
  • 99+ full patent PDF documents of Kinetics-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Conjugation of lipophilic albumin-binding moiety to rna for improved carrier-free in vivo pharmacokinetics and gene ...
Vanderbilt University
March 08, 2018 - N°20180064749

Provided herein are compounds and methods for gene silencing. The compound includes a rna directly conjugated to an albumin-binding group. The method includes administering a compound comprising a rna directly conjugated to an albumin-binding group to a subject in need thereof.
Ex vivo liquid biopsy
Helomics Corporation
February 22, 2018 - N°20180052168

Embodiments disclosed herein provide in vitro methods for use in the culture and biochemical analysis of normal or malignant cells in autologous, allogeneic, and xenogeneic fluids and the biomarkers secreted from those cells over time and in response to various changing conditions. The methods disclosed herein provide a clinical diagnostic and research platform that provides for the study of fundamental ...
Pharmaceutical compositions comprising meloxicam
Axsome Therapeutics, Inc.
February 22, 2018 - N°20180050106

Disclosed herein are compositions comprising an nsaid such as meloxicam in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the nsaid for the treatment of conditions such as pain.
Compounds and methods for modulating pharmacokinetics
The Brigham And Women's Hospital, Inc.
February 15, 2018 - N°20180044396

Methods and compositions are described for management of the pharmacokinetic properties of active agents, e. G., therapeutic moieties, by conjugating, fusing, or non-direct linkage of the active agent to one or more wild-type or modified heparin-binding peptides (hb). Compounds may be administered to tissues including skin. Contemplated uses include treatment of disease, allergen immunotherapy, and immunization. Other aspects relate to ...
Metabolic syndrome treatment
Arkay Therapeutics, Llc
February 15, 2018 - N°20180042945

Formulations and methods of providing an orally-active anti-metabolic disease fixed dose combinations (fdc) for use as personalized medicine to treat different components of the metabolic syndrome or insulin resistance syndrome such as type ii diabetes, hypertension, hyperlipidemia and obesity are disclosed. Pharmaceutical compositions of anti-inflammatory centric drug formulations and methods comprising of nsaids in general and selective cox-2 inhibitors in ...
Methods for making controlled delivery devices having zero order kinetics
Board Of Regents, The University Of Texas System
February 15, 2018 - N°20180042549

A method of making an injectable or implantable active agent delivery device capable of delivering a diagnostic, therapeutic, and/or prophylactic agent to a desired targeted site having orifice(s) on the surface is disclosed herein providing unidirectional release of the agent at a controlled desirable rate. The agent may include, but is not limited to, drugs, proteins, peptides, biomarkers, ...
Novel c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens, in vitro biological activities, pharmacokinetics and antitumor activity
The University Of Maryland, Baltimore
February 08, 2018 - N°20180036320

Described are steroidal c-17 benzoazoles, pyrimidinoazoles (azabenzoazoles) and diazines. Methods for their synthesis are also described, which include methods having a step of nucleophilic vinylic “addition-elimination” substitution reaction of 3β-acetoxy-17-chloro-16-formylandrosta-5,16-diene or analogs thereof and benzoazole or pyrimidinoazole nucleophiles and methods having a palladium catalyzed cross-coupling reaction of 17-iodoandrosta-5,16-dien-3β...
Kinetics Patent Pack
Download 99+ patent application PDFs
Kinetics Patent Applications
Download 99+ Kinetics-related PDFs
For professional research & prior art discovery
inventor
  • 99+ full patent PDF documents of Kinetics-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method for selecting anticancer agent based on protein damage information of individual to prevent anticancer ...
Cipherome, Inc.
February 01, 2018 - N°20180032664

The present invention relates to a method and a system for selecting an anticancer agent based on protein damage information of an individual by using individual genome sequencing. The method and the system, according to the present invention, are highly reliable and widely applicable techniques capable of predicting side effects or risks of specific drugs, in other words, anticancer agents, ...
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Clarus Therapeutics, Inc.
February 01, 2018 - N°20180028542

A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e. G., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided.
Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
Corium International, Inc.
February 01, 2018 - N°20180028467

A method for delivering a therapeutic agent to a subject from a transdermal delivery system is described, where the therapeutic agent (i) has a half-life in the blood when delivered orally of greater than about 48 hours and (ii) is for the treatment of a chronic condition. The transdermal delivery system achieves transdermal delivery of the therapeutic agent at steady state ...
Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
Corium International, Inc.
February 01, 2018 - N°20180028461

A method for delivering a therapeutic agent to a subject from a transdermal delivery system is described, where the therapeutic agent (i) has a half-life in the blood when delivered orally of greater than about 48 hours and (ii) is for the treatment of a chronic condition. The transdermal delivery system achieves transdermal delivery of the therapeutic agent at steady state ...
Sunitinib prodrug and pharmaceutical composition
Sound Biopharmaceuticals Ltd.
January 25, 2018 - N°20180022734

The present invention provides a sunitinib prodrug having formula i, wherein r12, r13 are selected from the group consisting of h, c1-c6 alkyl, c2-c6 alkenyl, c2-c6 alkynyl, c3-c8 cycloalkyl, c6-c10 aryl, 4-15 membered heterocyclyl and 5-15 membered heteroaryl; r14 is selected from the group consisting of r′, or′, sr′ and n(r&#...
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Clarus Therapeutics, Inc.
January 25, 2018 - N°20180021351

A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e. G., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided.
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Clarus Therapeutics, Inc.
January 25, 2018 - N°20180021350

A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e. G., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided.
Modified release gamma- hydroxybutyrate formulations having improved pharmacokinetics
Flamel Ireland Limited
January 25, 2018 - N°20180021284

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
Loading